Centre Leon Berard: Carcinoma trials

The registry lists 17 Carcinoma studies with Centre Leon Berard as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 6Phase 3 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Heterogeneity of Oral Squamous Cell Carcinoma Analysis by Single Cell RNA SequencingNot yet recruitingNCT06861036Not applicable
• Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO)RecruitingNCT06425146Not applicable
• FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and PlatinumRecruitingNCT06393816Phase 2
• Axitinib +/- Pembrolizumab in First Line Treatment of mPRCCRecruitingNCT05096390Phase 2
• Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)CompletedNCT03421912Not applicable
• A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCCTerminatedNCT03276819Not applicable
• Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)Active, not recruitingNCT02730923Phase 1/2
• Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of LumpectomyCompletedNCT02576106Not applicable
• Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell CarcinomaCompletedNCT02489695Phase 2
• Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorTerminatedNCT02400424Not applicable
• Protocole Advanced RadioTherapy ORLCompletedNCT02024035
• Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)WithdrawnNCT02014831Phase 2
• Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and NeckCompletedNCT01427478Phase 3
• Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive TractStatus unknownNCT01361100Not applicable
• Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid TumorsCompletedNCT01202032Phase 1
• Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell CarcinomaCompletedNCT00619268Phase 2
• Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate PrognosisCompletedNCT00291369Phase 3